For example, in the study of Xu et al., tight associations between the high expression of TSC22D3 domain family genes playing an essential role in tumor progression with poor overall and event-free survival and drug resistance to BCL2 inhibitors in adult AML patients, especially in the chemotherapy group, have been reported [47]. The gene discussed is TSC22D3; the disease is acute myeloid leukemia.